Pākuʻi Oxybutynin Transdermal

Anter

• E hoʻohana ai i nā pākuʻi, e hāhai i kēia mau kaʻina hana:
• Ma mua o ka hoʻohana ʻana i ka oxybutynin transdermal,
• Hiki i ka transdermal oxybutynin ke kumu i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. ʻAʻole ʻike ʻia nā ʻōuli aʻe, akā inā ʻike ʻoe i kekahi o ia mau mea, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.
• Hiki i nā ʻōuli o ka overdose ke hoʻopili i kēia mau mea:

Hoʻohana ʻia nā pālolo Oxybutynin transdermal e mālama i kahi bladder overactive (kahi kūlana e ʻaelike ʻole ai nā mākāhā a hana pinepine i ka urination, pono i ka mimiki, a me ka hiki ʻole ke kāohi i ka mimi). Aia ʻo Oxybutynin i kahi papa o nā lāʻau i kapa ʻia antimuscarinics. Hana ia e ka hoʻomaha ʻana i nā mākala o ka ʻai.

Hele mai ka transdermal oxybutynin ma ke ʻano he patch e hoʻopili i ka ʻili. Hoʻohana maʻamau ia i ʻelua mau manawa i kēlā me kēia pule (i kēlā me kēia 3-4 lā). Pono ʻoe e hoʻopili i ka oxybutynin transdermal ma nā lā 2 like o ka pule i kēlā me kēia pule. No ke kōkua ʻana iā ʻoe e hoʻomanaʻo e hoʻopili i kāu mau pā i nā lā kūpono, pono ʻoe e māka i ka kalena ma ka hope o kāu pūʻolo lāʻau. E hāhai pono i nā ʻōkuhi i kāu lepili kuhikuhi, a nīnau i kāu kauka a kauka paha e wehewehe i kahi ʻāpana āu i maopopo ʻole ai. E hoʻohana pono i ka oxybutynin transdermal e like me ke kuhikuhi. Mai hoʻopili pinepine i nā pāhono ma mua o ka mea i kau ʻia e kāu kauka.

Hiki iā ʻoe ke hoʻopili i nā patch oxybutynin ma nā wahi āpau o kou ʻōpū, nā pūhaka, a i ʻole nā ​​ʻūlū koe ka wahi a puni kou pūhaka.Koho i kahi e manaʻo ai ʻoe e ʻoluʻolu ka pīpī nāu, kahi e ʻānai ʻole ʻia ai e ka lole paʻa, a kahi e pale ʻia ai mai ka lā e ka lole. Ma hope o kou hoʻopili ʻana i kahi pāʻā i kahi wahi, kali ma ka liʻiliʻi he 1 pule ma mua o ka hoʻopili ʻana i kahi pāʻina ʻē aʻe i kēlā wahi. Mai hoʻopili i nā pākuʻi i ka ʻili i loaʻa nā wrinkles a i ʻole nā ​​pelu; ua mālama koke ʻoe me ka wai aila, ka aila, a me ka pauka. a ʻaila paha, ʻoki, ʻoki ʻia, a hoʻonāukiuki ʻia paha. Ma mua o ka hoʻopili ʻana i kahi āpau, e hoʻomaopopo he maʻemaʻe a maloʻo ka ʻili.

Ma hope o kāu hoʻopili ʻana i kahi oxybutynin patch, pono ʻoe e ʻaʻalo ia i nā manawa āpau a hiki i kou mākaukau e hemo a kau i kahi pale hou. Inā hemo ka pale a hāʻule paha ma mua o ka manawa e pani ai, e hoʻāʻo e kaomi hou i kahi me nā manamana lima. Inā ʻaʻole hiki ke kaomi i ka pale, hoʻolei iā ia a kau i kahi pale hou i kahi ʻokoʻa. Hoʻololi i ka pīpī hou i kāu lā loli patch hou i hoʻonohonoho ʻia.

Hiki iā ʻoe ke ʻauʻau, ʻauʻau, ʻauʻau, a hoʻoikaika kino paha i kou wā e ʻaʻa nei i ka patch oxybutynin. Eia nō naʻe, e hoʻāʻo e hamo ʻole i ka pā i kēia mau hana, a mai kuʻu i loko o ka pahu wai wela no kahi manawa lōʻihi i ka wā e kau ana i ka pā.

Mālama ʻo Transdermal oxybutynin i nā ʻōuli o ka bladder overactive akā ʻaʻole ia e hoʻōla i ke ʻano. E hoʻomau i ka lawe i ka oxybutynin transdermal ʻoiai ʻoe e manaʻo maikaʻi. Mai hoʻōki i ka lawe ʻana i ka oxybutynin transdermal me ke kamaʻilio ʻole ʻana me kāu kauka.

E hoʻohana ai i nā pākuʻi, e hāhai i kēia mau kaʻina hana:

1. E wehe i ka ʻeke pale a hemo i ka pā.
2. Peel i ka ʻāpana mua o ka liner mai ka ʻaoʻao pipiki o ka pākuʻi. Pono e paʻa ka lua o ka liner i ka pā.
3. E kaomi paʻa i ka pale ma luna o kou ʻili me ka ʻaoʻao pili i lalo. E makaʻala i ʻole e hoʻopā i ka ʻaoʻao pipiki me kou mau manamana lima.
4. Kulou i ka pale i ka hapalua a hoʻohana i kou manamana lima e olokaa i ka hapa i koe o ka patch i kou ʻili. Pono e hāʻule ke kaula liner ʻelua mai ka pāʻina ke hana ʻoe i kēia.
5. E kaomi paʻa i ka ʻili o ka pale e hoʻopili paʻa ai i kou ʻili.
6. Ke mākaukau ʻoe e hemo i kahi āpau, ʻili mālie a mālie hoʻi. E pelu i ka pā i ka hapalua me nā ʻaoʻao pili a hoʻolei iā ia me ka palekana, i ke ala i hiki ʻole ai i nā keiki a me nā holoholona. Hiki ke hōʻeha ʻia nā keiki a me nā holoholona inā nau lākou, pāʻani me, a ʻaʻahu paha i nā loʻi i hoʻohana ʻia.
7. E holoi i ka wahi ma lalo o ka palapū me ke kopa me ka wai mehana e hoʻoneʻe i nā koena. Inā pono, hiki iā ʻoe ke hoʻohana i ka aila pēpē a i ʻole ka pale wehe lina lapaʻau e lawe i ke koena e hele ʻole me ke kopa a me ka wai. Mai hoʻohana i ka wai ʻona, mea hoʻoneʻe kui, a i ʻole nā ​​mea hoʻoheheʻe ʻē aʻe.
8. E noi i kahi pākuʻi hou i kahi ʻokoʻa ʻē aʻe ma ka hāhai ʻana i nā ʻanuʻu he 1-5.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka hoʻohana ʻana i ka oxybutynin transdermal,

• e haʻi aku i kāu kauka a me ka mea kauka lāʻau inā he maʻi ʻoe i ka oxybutynin (Ditropan, Ditropan XL, Oxytrol), nā lāʻau ʻē aʻe, nā huahana lipine lapaʻau, a i ʻole nā ​​ʻili ʻili ʻē aʻe.
• e haʻi i kāu kauka a me ka mea kauka lāʻau he aha nā lāʻau lapaʻau a me nā lāʻau ʻole i kuhikuhi ʻia, nā wikamina, nā mea hoʻopihaʻai a me nā huahana lāʻau āu e lawe nei. E hoʻomaopopo pono e ʻōlelo i kekahi o kēia mau mea: antihistamines (i ka kahe a me nā lāʻau anuanu); ipratropium (Atrovent); nā lāʻau no ka osteoporosis a i ʻole nā ​​maʻi iwi e like me alendronate (Fosamax), etidronate (Didronel), ibandronate (Boniva), a me risedronate (Actonel); nā lāʻau no ka maʻi hanu huhū, ka neʻe ʻana o ka maʻi, ka maʻi ʻo Parkinson, nā maʻi ulcer, a me nā pilikia urinary; a me nā lāʻau ʻē aʻe i hoʻohana ʻia e mālama i ka bladder overactive. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• E haʻi i kāu kauka inā loaʻa a loaʻa paha iā ʻoe ka huina huina glaucoma (kahi maka maka koʻikoʻi e hiki ai ke lilo i ka ʻike maka), kekahi ʻano e hōʻoki ana i kāu ʻōpū mai ka waiho ʻana a pau, a i ʻole kekahi ʻano e hoʻolōʻihi i kou ʻōpū. E haʻi paha kāu kauka iā ʻoe mai hoʻohana i nā lāʻau oxybutynin.
• e haʻi i kāu kauka inā loaʻa iā ʻoe a i ʻole o kekahi o kou ʻohana a i ʻole loaʻa i kekahi ʻano o ka poloka i loko o ka ʻōpū a me ka ʻōnaehana digestive; ʻO ka maʻi reflux gastroesophageal (GERD, kahi ʻano e hoʻi ai nā mea o ka ʻōpū i loko o ka esophagus a hana i ka ʻeha a me ka puʻuwai puʻuwai); myasthenia gravis (kahi maʻi o ka ʻōnaehana hopohopo e kumu i ka nāwaliwali o nā mākala); ulcerative colitis (kahi ʻano e kumu ai ka pehu ʻana a me nā ʻeha i ka uhi ʻana o ke kolona [ʻōpū nui] a me ka poli); benign prostatic hypertrophy (BPH, hoʻonui o ka prostate, kahi kāne kāne hānau); aiʻole ka ate a me nā maʻi pākī.
• e haʻi i kāu kauka inā hāpai ʻoe, hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka hoʻohana ʻana i ka oxybutynin transdermal, e kāhea i kāu kauka.
• inā ke ʻoki nei ʻoe, e like me ke kaha ʻana o ka niho, e haʻi i ke kauka a i ʻole kauka niho paha e hoʻohana nei ʻoe i ka transdermal oxybutynin.
• pono ʻoe e ʻike i ka transdermal oxybutynin e hoʻomoe ai a hiamoe paha i kāu ʻike. Mai hoʻokele i kahi kaʻa a hana i nā mīkini a ʻike ʻoe i ka hopena o kēia lāʻau iā ʻoe.
• E hoʻomanaʻo hiki i ka waiʻona ke hoʻohui i ka hiamoe i hoʻokumu ʻia e kēia lāʻau.
• pono ʻoe e ʻike i ka transdermal oxybutynin i mea e paʻakikī ai i kou kino e hoʻalili i ka wā e wela nui ana. Hōʻalo i ka wela loa, a kāhea aku i kāu kauka a i ʻole e loaʻa i ka lāʻau olakino olakino inā loaʻa ʻoe i ke kuni a i ʻole nā ​​hōʻailona ʻē aʻe o ka hahau wela e like me ka hoʻoluhi, ʻōpū huhū, ʻeha poʻo, huikau, a me ka wikiwiki wikiwiki ma hope o kou ʻike ʻia i ka wela.

E kamaʻilio me kāu kauka e pili ana i ka inu ʻana i ka wai huaʻomaʻo i ka lawe ʻana i kēia lāʻau.

Wehe i ka pale kahiko a kau i kahi patch hou i kahi wahi ʻē aʻe ke hoʻomanaʻo ʻoe iā ia. E kuapo i ka pale hou ma kāu lā loli hou o ka patch. Mai hoʻopili i ʻelua mau pākuʻi e pani ai no ka mahele lāʻau i hala a mai ʻaihue ma mua o hoʻokahi pāka i ka manawa.

Hiki i ka transdermal oxybutynin ke kumu i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• ʻulaʻula, puhi ʻana, a i ʻole ʻūlū ma kahi āu i noi ai i kahi pā
• waha maloo
• kōpaʻa
• ʻeha ka ʻōpū
• ʻenekini
• hoʻohuhū ʻōpū
• luhi loa
• hiamoe
• ʻeha poʻo
• ʻike hihi
• ʻōhinu
• ʻeha kua

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. ʻAʻole ʻike ʻia nā ʻōuli aʻe, akā inā ʻike ʻoe i kekahi o ia mau mea, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

• ʻehu ma nā wahi āpau o ke kino
• hives
• pehu o nā maka, maka, lehelehe, alelo, a puʻu paha
• hulahula
• pilikia i ka hanu ʻana a i ʻole ke ale ʻana
• pinepine, wikiwiki, a i ʻole urination ʻeha

Hiki i ka transdermal oxybutynin ke kumu i nā hopena ʻē aʻe. Kāhea i kāu kauka inā loaʻa iā ʻoe kekahi pilikia maʻamau i ka hoʻohana ʻana i kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E mālama i kēia lāʻau i loko o ka pahu i komo ai, pani paʻa ʻia, a ʻaʻole hiki i nā kamaliʻi. E mālama i nā loʻi i kā lākou mau pale pale a mai wehe i kahi ʻeke a hiki i kou mākaukau e hoʻopili i ka pā. E mālama i kēia lāʻau i ka mahana wela o ka lumi a ma kahi o ka wela a me ka momona (ʻaʻole i loko o ka lua.

Pono e hoʻolei ʻia nā lāʻau i koi ʻole ʻia i nā ala kūikawā e hōʻoia i ka hiki ʻole i nā holoholona, ​​nā keiki, a me nā poʻe ʻē aʻe ke hoʻopau iā lākou. Eia nō naʻe, ʻaʻole pono ʻoe e kaomi i kēia lāʻau i ka lua. Akā, ʻo ke ala ʻoi loa e hoʻolilo i kāu lāʻau i loko o kahi papahana hoʻihoʻi lāʻau. E kamaʻilio me kāu kauka lāʻau a kāhea paha i kāu ʻōpala a me nā hana hoʻopōʻaiapuni kūloko e aʻo e pili ana i nā papahana hoʻihoʻi i kou kaiāulu. E ʻike i ka pūnaewele palekana o kā FDA's Disposal of Medicines (http://goo.gl/c4Rm4p) no ka ʻike hou aku inā ʻaʻohe ou komo i kahi papahana hoʻihoʻi.

He mea nui e mālama i nā lāʻau āpau mai ka maka a hiki i nā keiki e like me nā ipu (e like me nā minder pill i kēlā me kēia pule a me nā mea no nā kulu maka, nā kalima, nā pākuʻi, a me nā inhalers) ʻaʻole pale keiki a hiki i nā keiki ʻōpio ke wehe maʻalahi iā lākou. No ka pale ʻana i nā keiki ʻōpio mai ka lāʻau make, laka mau i nā pāpale palekana a kau koke i ka lāʻau i kahi palekana - kahi i luna a mamao a mai ko lākou alo a hiki. http://www.upandaway.org

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

Hiki i nā ʻōuli o ka overdose ke hoʻopili i kēia mau mea:

• ʻōhinu
• fiva
• kōpaʻa
• ʻili maloʻo
• maka pohō
• luhi loa
• kuʻi puʻuwai ʻole
• ka luaʻi
• hiki ʻole ke mimī
• poho hoʻomanaʻo
• kūlana semi-awakea
• huikau
• haumana ākea

Mālama i nā manawa āpau me kāu kauka

Mai ʻae i kahi mea ʻē aʻe e lawe i kāu lāʻau. E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka hoʻopiha hou ʻana i kāu kuhikuhi.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• ʻOxyxytrol^®